{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:36:19Z","timestamp":1790206579786,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020251","name":"Nederlands Herseninstituut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020251","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ymthe.2025.06.026","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T11:04:11Z","timestamp":1749899051000},"page":"4360-4380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A single dose of a vectorized mAb targeting TDP-43 potently inhibits the neuropathology in a model of ALS\/FTD"],"prefix":"10.1016","volume":"33","author":[{"given":"Greg del","family":"Val","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Gauye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micka\u00ebl","family":"Audrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Menant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monisha","family":"Ratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Ollier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Seredenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Afroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Kosco-Vilbois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0981-5703","authenticated-orcid":false,"given":"Damien","family":"Nevoltris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.06.026_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","article-title":"Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis","volume":"12","author":"Prasad","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.026_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.06.026_bib3","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1007\/s12035-022-02847-x","article-title":"The Role of TDP-43 in Neurodegenerative Disease","volume":"59","author":"Liao","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.abq7860","article-title":"Two FTD-ALS genes converge on the endosomal pathway to induce TDP-43 pathology and degeneration","volume":"378","author":"Shao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.06.026_bib5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2025.06.026_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00401-016-1666-6","article-title":"ALS\/FTLD: experimental models and reality","volume":"133","author":"Tan","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib7","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S1474-4422(10)70195-2","article-title":"TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"9","author":"Mackenzie","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","article-title":"TDP-43 Pathology in Alzheimer's Disease","volume":"16","author":"Meneses","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ymthe.2025.06.026_bib9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1517\/14712598.8.7.969","article-title":"TDP-43 in neurodegenerative disorders","volume":"8","author":"Cook","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.026_bib10","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies","volume":"52","author":"Jo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.06.026_bib11","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/brain\/awz078","article-title":"The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?","volume":"142","author":"Hergesheimer","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2025.06.026_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cells12111523","article-title":"Current State and Future Directions in the Therapy of ALS","volume":"12","author":"Tzeplaeff","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2025.06.026_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102495","article-title":"Effects of tofersen treatment in patients with SOD1-ALS in a \u201creal-world\u201d setting - a 12-month multicenter cohort study from the German early access program","volume":"69","author":"Wiesenfarth","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ymthe.2025.06.026_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106050","article-title":"Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS\/FTD","volume":"179","author":"Afroz","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2025.06.026_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2025.06.026_bib16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/19420862.2015.1008351","article-title":"Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells","volume":"7","author":"Chng","year":"2015","journal-title":"MAbs"},{"key":"10.1016\/j.ymthe.2025.06.026_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jbiosc.2020.03.009","article-title":"Production of an antibody Fab fragment using 2A peptide in insect cells","volume":"130","author":"Mizote","year":"2020","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.ymthe.2025.06.026_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.68","article-title":"Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies","volume":"3","author":"Fuchs","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.06.026_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jbiotec.2013.03.019","article-title":"Control of IgG LC:HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability","volume":"165","author":"Ho","year":"2013","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-1-4939-8648-4_17","article-title":"An IRES-Mediated Tricistronic Vector for Efficient Generation of Stable, High-Level Monoclonal Antibody Producing CHO DG44 Cell Lines","volume":"1827","author":"Yeo","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.717689","article-title":"Shelf-Life Extension of Fc-Fused Single Chain Fragment Variable Antibodies by Lyophilization","volume":"11","author":"Schneider","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.omtm.2019.08.015","article-title":"Clinical Considerations for Capsid Choice in the Development of Liver-Targeted AAV-Based Gene Transfer","volume":"15","author":"Pipe","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.06.026_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188830","article-title":"Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection","volume":"12","author":"Hammond","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.06.026_bib24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/mt.2015.212","article-title":"A Comprehensive Map of CNS Transduction by Eight Recombinant Adeno-associated Virus Serotypes Upon Cerebrospinal Fluid Administration in Pigs","volume":"24","author":"Sorrentino","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.026_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2015.07.006","article-title":"Adeno-associated virus serotypes for gene therapeutics","volume":"24","author":"Lisowski","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.15252\/emmm.201506078","article-title":"A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases","volume":"8","author":"Korbelin","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.06.026_bib27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/jnc.13898","volume":"140","author":"Weber-Adrian","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymthe.2025.06.026_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/321209","article-title":"Astrocyte-secreted matricellular proteins in CNS remodelling during development and disease","volume":"2014","author":"Jones","year":"2014","journal-title":"Neural Plast."},{"key":"10.1016\/j.ymthe.2025.06.026_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/sj.gt.3301905","article-title":"Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area","volume":"10","author":"K\u00fcgler","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.026_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1113\/expphysiol.2004.028159","article-title":"Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo","volume":"90","author":"Shevtsova","year":"2005","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib31","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors","volume":"22","author":"Gray","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.026_bib32","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1093\/nar\/gku1111","article-title":"The Eukaryotic Promoter Database: expansion of EPDnew and new promoter analysis tools","volume":"43","author":"Dreos","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.06.026_bib33","first-page":"D65","article-title":"EPD in 2020: enhanced data visualization and extension to ncRNA promoters","volume":"48","author":"Meylan","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.06.026_bib34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jimd.12637","article-title":"Liver directed adeno-associated viral vectors to treat metabolic disease","volume":"47","author":"Chuecos","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2025.06.026_bib35","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2002-09-2889","article-title":"Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway","volume":"102","author":"Davidoff","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.06.026_bib36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/hum.2006.17.601","article-title":"Intrahepatic injection of recombinant adeno-associated virus serotype 2 overcomes gender-related differences in liver transduction","volume":"17","author":"Berraondo","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.026_bib37","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1089\/hum.2009.031","article-title":"Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders","volume":"20","author":"Pa\u00f1eda","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.026_bib38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.omtm.2019.06.002","article-title":"AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 Region","volume":"14","author":"van den Berg","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.06.026_bib39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.ymthe.2025.06.026_bib40","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.06.026_bib41","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1038\/s41467-018-06548-9","article-title":"Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo","volume":"9","author":"Porta","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.06.026_bib42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molmed.2021.09.007","article-title":"Delivery of therapeutic AAV9 vectors via cisterna magna to treat neurological disorders","volume":"28","author":"Marchi","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2025.06.026_bib43","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s41591-024-02973-0","article-title":"Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1\/2 trial interim results","volume":"30","author":"Sevigny","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.06.026_bib44","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1172\/JCI44867","article-title":"Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice","volume":"121","author":"Igaz","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.06.026_bib45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s40478-024-01867-z","article-title":"Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS\/FTD","volume":"12","author":"Chevalier","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2025.06.026_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.857276","article-title":"Overcoming the Challenges Imposed by Humoral Immunity to AAV Vectors to Achieve Safe and Efficient Gene Transfer in Seropositive Patients","volume":"13","author":"Gross","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib47","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.tibtech.2022.11.006","article-title":"Evading and overcoming AAV neutralization in gene therapy","volume":"41","author":"Earley","year":"2023","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib48","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.7150\/thno.89380","article-title":"Understanding AAV vector immunogenicity: from particle to patient","volume":"14","author":"Dhungel","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2025.06.026_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158009","article-title":"Recombinant AAV Vectors for Enhanced Expression of Authentic IgG","volume":"11","author":"Fuchs","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.06.026_bib50","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41434-021-00311-4","article-title":"Rapid characterization of adeno-associated virus (AAV) gene therapy vectors by mass photometry","volume":"29","author":"Wu","year":"2022","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.026_bib51","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.nbd.2006.04.012","article-title":"Anti-Abeta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease","volume":"23","author":"Fukuchi","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2025.06.026_bib52","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI123931","article-title":"Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology","volume":"129","author":"Pozzi","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.06.026_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226245","article-title":"Gene delivery of a modified antibody to Abeta reduces progression of murine Alzheimer's disease","volume":"14","author":"Elmer","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.06.026_bib54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1124\/jpet.119.261180","article-title":"The development and characterization of an scFv-Fc fusion based gene therapy to reduce the psychostimulant effects of methamphetamine abuse","volume":"374","author":"Hay","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymthe.2025.06.026_bib55","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nm.1967","article-title":"Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys","volume":"15","author":"Johnson","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.06.026_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005090","article-title":"AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity","volume":"11","author":"Fuchs","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2025.06.026_bib57","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fimmu.2020.00449","article-title":"Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV","volume":"11","author":"Martinez-Navio","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib58","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.immuni.2019.02.005","article-title":"Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression","volume":"50","author":"Martinez-Navio","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.06.026_bib59","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809824","article-title":"AAV-mediated delivery of an anti-BACE1 VHH alleviates pathology in an Alzheimer's disease model","volume":"14","author":"Marino","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.06.026_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.870799","article-title":"AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System","volume":"13","author":"Marino","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/biom10121663","article-title":"An Inside Job: Applications of Intracellular Single Domain Antibodies","volume":"10","author":"Soetens","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymthe.2025.06.026_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22101695","article-title":"Production of Single-Chain Fv Antibodies Specific for GA-Pyridine, an Advanced Glycation End-Product (AGE), with Reduced Inter-Domain Motion","volume":"22","author":"Fukuda","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ymthe.2025.06.026_bib63","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jmb.2006.06.073","article-title":"Structure-based Stability Engineering of the Mouse IgG1 Fab Fragment by Modifying Constant Domains","volume":"361","author":"Teerinen","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib64","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.molimm.2006.05.009","article-title":"The change of the scFv into the Fab format improves the stability and in vivo toxin neutralization capacity of recombinant antibodies","volume":"44","author":"Quintero-Hern\u00e1ndez","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib65","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib66","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrm934","article-title":"Furin at the cutting edge: from protein traffic to embryogenesis and disease","volume":"3","author":"Thomas","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib67","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/s41598-017-02460-2","article-title":"Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.06.026_bib68","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/gt.2008.90","article-title":"Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition","volume":"15","author":"Yang","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.026_bib69","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1093\/nar\/gkr1176","article-title":"2A peptides provide distinct solutions to driving stop-carry on translational recoding","volume":"40","author":"Sharma","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.06.026_bib70","article-title":"High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.06.026_bib71","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.celrep.2019.03.023","article-title":"Fusion of Reprogramming Factors Alters the Trajectory of Somatic Lineage Conversion","volume":"27","author":"Velychko","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2025.06.026_bib72","doi-asserted-by":"crossref","first-page":"8334","DOI":"10.1128\/JVI.00908-15","article-title":"Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection","volume":"89","author":"Saunders","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib73","article-title":"Self-cleaving peptides for expression of multiple genes in Dictyostelium discoideum","volume":"18","author":"Zhu","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.06.026_bib74","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/mthe.2000.0050","article-title":"IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector","volume":"1","author":"Mizuguchi","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.026_bib75","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jbiotec.2011.09.023","article-title":"IRES-mediated Tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines","volume":"157","author":"Ho","year":"2012","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib76","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.bbadis.2015.10.014","article-title":"Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease","volume":"1862","author":"Simon","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2025.06.026_bib77","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1089\/hum.2023.060","article-title":"Positron Emission Tomography Quantitative Assessment of Off-Target Whole-Body Biodistribution of I-124-Labeled Adeno-Associated Virus Capsids Administered to Cerebral Spinal Fluid","volume":"34","author":"Rosenberg","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.026_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146832","article-title":"Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies","volume":"1739","author":"Bailey","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.ymthe.2025.06.026_bib79","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1089\/hum.2020.116","article-title":"Quantitative Whole-Body Imaging of I-124-Labeled Adeno-Associated Viral Vector Biodistribution in Nonhuman Primates","volume":"31","author":"Ballon","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.026_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2015.55","article-title":"AAV9-mediated central nervous system-targeted gene delivery via cisterna magna route in mice","volume":"3","author":"Lukashchuk","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.06.026_bib81","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib82","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/s42003-022-04200-3","article-title":"Development of microglia-targeting adeno-associated viral vectors as tools to study microglial behavior in vivo","volume":"5","author":"Okada","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib83","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41434-021-00244-y","article-title":"Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9","volume":"29","author":"Chatterjee","year":"2022","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.026_bib84","article-title":"An AAV capsid reprogrammed to bind human Transferrin Receptor mediates brain-wide gene delivery","author":"Huang","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2025.06.026_bib85","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/s41565-023-01419-x","article-title":"Adeno-associated viral vectors for functional intravenous gene transfer throughout the non-human primate brain","volume":"18","author":"Chuapoco","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib86","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.06.026_bib87","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1212\/WNL.94.15_supplement.4143","article-title":"Cerebrospinal Fluid TDP-43 is a Possible Predictor of Survival in Amyotrophic Lateral Sclerosis (4143)","volume":"94","author":"Zecca","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2025.06.026_bib88","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-008-0456-1","article-title":"Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"117","author":"Kasai","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2025.06.026_bib89","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/gt.2009.157","article-title":"High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency","volume":"17","author":"Ayuso","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.026_bib90","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/glia.20622","article-title":"GFAP promoter elements required for region-specific and astrocyte-specific expression","volume":"56","author":"Lee","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.ymthe.2025.06.026_bib91","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(85)80025-8","article-title":"A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus","volume":"41","author":"Boshart","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.06.026_bib92","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41593-018-0294-y","article-title":"TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates","volume":"22","author":"Laferri\u00e8re","year":"2019","journal-title":"Nat. Neurosci."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625004770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625004770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:21:59Z","timestamp":1782505319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625004770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":92,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1525001625004770"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.06.026","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single dose of a vectorized mAb targeting TDP-43 potently inhibits the neuropathology in a model of ALS\/FTD","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}